<p>IFNγ levels (in pg/ml±SD) in supernatants of splenocytes derived at 96 hr and 7 and 14 days after treatment from naïve, PBS and Delta24-RGD treated mice and cocultured with Delta24-RGD (A) or GL261 cells (B). The IFNγ levels were corrected for those produced by splenocytes cocultured with the control cell line A549.</p
We investigated the cytotoxic activity of γδ-receptor bearing T cells against glioma cells. Highly e...
Background Glioblastoma (GBM) is a devastating primary brain tumor with a highly immunosuppressive t...
Pediatric high-grade glioma (pHGG) and diffuse intrinsic pontine gliomas (DIPGs) are aggressive pedi...
<p>A. Delta-24-RGD was injected into the intracranial tumor on days 4, 7, 9 after tumor implantation...
<p>20 days after GL261 implantation and 9 days Delta-24-RGD injections, as indicated in <a href="htt...
Emerging evidence suggests anti-cancer immunity is involved in the therapeutic effect induced by onc...
The conditionally replicating oncolytic adenovirus Delta24-RGD (Ad) is currently under investigation...
<p>A) GL261 cells were seeded and infected in triplicate with a viral dose ranging from 200 to 800 M...
Background: Emerging evidence suggests anti-cancer immunity is involved in the therapeutic effect in...
<p>A &B. Gl261 cells were infected with Delta-24-RGD (D24-RGD) at the indicated dose (pfu/cell). 72 ...
<p>A. OVA expression in GL261-OVA and B16-OVA cells. Whole cell lysates were analyzed by immunoblott...
The oncolytic adenovirus Delta24-RGD represents a new promising therapeutic agent for patients with ...
The oncolytic adenovirus Delta24-RGD represents a new promising therapeutic agent for patients with ...
textabstractThe oncolytic adenovirus Delta24-RGD represents a new promising therapeutic agent for pa...
The tumor microenvironment of glioblastoma is extremely immunosuppressive due to high amount of myel...
We investigated the cytotoxic activity of γδ-receptor bearing T cells against glioma cells. Highly e...
Background Glioblastoma (GBM) is a devastating primary brain tumor with a highly immunosuppressive t...
Pediatric high-grade glioma (pHGG) and diffuse intrinsic pontine gliomas (DIPGs) are aggressive pedi...
<p>A. Delta-24-RGD was injected into the intracranial tumor on days 4, 7, 9 after tumor implantation...
<p>20 days after GL261 implantation and 9 days Delta-24-RGD injections, as indicated in <a href="htt...
Emerging evidence suggests anti-cancer immunity is involved in the therapeutic effect induced by onc...
The conditionally replicating oncolytic adenovirus Delta24-RGD (Ad) is currently under investigation...
<p>A) GL261 cells were seeded and infected in triplicate with a viral dose ranging from 200 to 800 M...
Background: Emerging evidence suggests anti-cancer immunity is involved in the therapeutic effect in...
<p>A &B. Gl261 cells were infected with Delta-24-RGD (D24-RGD) at the indicated dose (pfu/cell). 72 ...
<p>A. OVA expression in GL261-OVA and B16-OVA cells. Whole cell lysates were analyzed by immunoblott...
The oncolytic adenovirus Delta24-RGD represents a new promising therapeutic agent for patients with ...
The oncolytic adenovirus Delta24-RGD represents a new promising therapeutic agent for patients with ...
textabstractThe oncolytic adenovirus Delta24-RGD represents a new promising therapeutic agent for pa...
The tumor microenvironment of glioblastoma is extremely immunosuppressive due to high amount of myel...
We investigated the cytotoxic activity of γδ-receptor bearing T cells against glioma cells. Highly e...
Background Glioblastoma (GBM) is a devastating primary brain tumor with a highly immunosuppressive t...
Pediatric high-grade glioma (pHGG) and diffuse intrinsic pontine gliomas (DIPGs) are aggressive pedi...